title: Use of GLP-1 mimetic in type 2 diabetes mellitus: is it the end of fragility fractures?
authors.affiliation: GEROM Groupe Etudes Remodelage Osseux et bioMatériaux - UPRES EA 4658 LHEA, IRIS-IBS Institut de Biologie en Santé, CHU d'Angers, LUNAM Université, 4 rue Larrey, 49933, Angers Cedex 09, France, guillaume.mabilleau@univ-angers.fr.
authors.forename: Guillaume
authors.initials: G
authors.lastname: Mabilleau
mesh_terms: D050723:Fractures, Bone / Q000453:epidemiology* / Q000209:etiology*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D018027:Receptors, Glucagon / Q000819:agonists*
chemical_list: D007004:Hypoglycemic Agents; D018027:Receptors, Glucagon